NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹466 Cr | ₹428 Cr | ₹439 Cr | ₹363 Cr | ₹369 Cr |
What is the latest Total Current Liabilities ratio of NEULAND LABORATORIES ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹466 Cr |
Mar2024 | ₹428 Cr |
Mar2023 | ₹439 Cr |
Mar2022 | ₹363 Cr |
Mar2021 | ₹369 Cr |
How is Total Current Liabilities of NEULAND LABORATORIES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹466 Cr | 8.89 | |
Mar2024 | ₹428 Cr | -2.57 | |
Mar2023 | ₹439 Cr | 20.87 | |
Mar2022 | ₹363 Cr | -1.45 | |
Mar2021 | ₹369 Cr | - |
Compare Total Current Liabilities of peers of NEULAND LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NEULAND LABORATORIES | ₹16,386.7 Cr | -3.5% | 9.7% | 16.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,478.0 Cr | -6.5% | -4.7% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,845.0 Cr | -7.1% | -11.5% | 32.7% | Stock Analytics | |
CIPLA | ₹120,121.0 Cr | -4.3% | -0.1% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,327.0 Cr | -5.8% | 6.1% | 13.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,907.8 Cr | -5.8% | -6.8% | -11% | Stock Analytics |
NEULAND LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NEULAND LABORATORIES | -3.5% |
9.7% |
16.9% |
SENSEX | -1.2% |
-3.5% |
-0.5% |
You may also like the below Video Courses